The Review : Tinospora Cordifolia An Effective Tretment as Anti- Leprotic Agent

Registration ID: IJNRD_188302

Published ID: IJNRD2303070

: Click Here to Get

Shital Subhash Khandagale, Madhuri Pawar, Dr. Kamble Hemant.V, Mr Waghmare Santosh.A

: Tinospora cordifolia, WHO, Menispermeaceae, Menispermeaceae, AETC, METC leprosy; Hansen’s disease;

Tinospora cordifolia, also known as "Guduchi," is used in the traditional ayurveda system to treat a number of diseases. The objective of this review is to provide an extensive literature analysis and overview of traditional and contemporary information about Tinospora cordifolia for human health. It is a native of India and is a glabrous, succulent, woody climbing plant. It does well in the tropical climate, regularly attains its optimum height, and scales the branches of big trees. Alkaloids, diterpenoid lactones, glycosides, steroids, sesquiterpenoid, phenolics, aliphatic compounds, and polysaccharides are just a few of the many kinds of substances that are isolated from Tinospora cordifolia. Tinospora cordifolia has been utilized in traditional medicine for centuries, and research shows that it offers pharmacological benefits including hypoglycemic, anti-inflammatory, hepatoprotective, immunemodulator activity, antioxidant, antitumor, antineoplastic, and antifertility activity. The World Health Organization, or WHO, around 80% of the 5.86 billion people living in the world rely on traditional medicine for their main healthcare, the majority of which use herbs or their active ingredients. Being mindful of the importance of crop rotation between other crops and medicinal plants or herbs is important. In the eight-year period from 2001 to 2008, their production represented more than 100% of all publications published worldwide; in the following eight years from 2009 to 2020, this share fell to 98.53%. About 70 genus and more than 350 species of the plant family Menispermeaceae can be found in tropical regions. Many body organs and tissues can be impacted by leprosy (Hansen's disease). Skin signs are effectively monitor in the early stages of a medical condition, giving them the first recognized symptoms to cause clinical suspicions. Peripheral nerves and the skin are the main sites of leprosy damage. The disease has been known about for many centuries well before time of the Bible. The classification of Hansen's illness has altered over many years as contemporary medical research advanced. Leprosy patients frequently experience prejudice, exclusion from society, social stigma, poor quality of life (QoL), low self-esteem, and irreversible disfigurements. Research have demonstrated that leprosy significantly lowers patients' quality of life. As leprosy is no longer emphasised in medical courses, practising doctors frequently do not detect

Published Paper   E-Certificate

Shital Subhash Khandagale, Madhuri Pawar, Dr. Kamble Hemant.V, & Mr Waghmare Santosh.A (March-2023). The Review : Tinospora Cordifolia An Effective Tretment as Anti- Leprotic Agent. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(3), a684-a690. https://ijnrd.org/papers/IJNRD2303070.pdf

Volume 8 Issue 3, March-2023

Pages : a684-a690

Paper Reg. ID: IJNRD_188302

Published Paper Id: IJNRD2303070

Downloads: 000122013

Research Area: Pharmacy

Author Type: Indian Author

Country: Pune, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2303070.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2303070

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details